IFN-γ, potentiates atherosclerosis in ApoE knock-out mice

Journal of Clinical Investigation

Volumn 99, Issue 11, 1997, Pages 2752-2761

  Gupta, Sanjay ^a   Pablo, Anne Marie ^a   Jiang, Xian Cheng ^a   Wang, Nan ^a   Tall, Alan R ^a   Schindler, Christian ^a  

^a Columbia University ^*  (United States)

Author keywords

Apolipoprotein deficient mice; Collagen; IFN ; T cells

Indexed keywords

APOLIPOPROTEIN A4; APOLIPOPROTEIN E; COLLAGEN; GAMMA INTERFERON; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; COLLAGEN SYNTHESIS; CONTROLLED STUDY; HELPER CELL; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0030974188     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119465     Document Type: Article

References (53)

1. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (Lond.). 362:801-809.
2. Hansson, G.K., J. Holm, and L. Jonasson. 1989. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135:169-175.
3. Wick, G., G. Schett, A. Amberger, R. Kleindienst, and Q. Xu. 1995. Is atherosclerosis an immunologically mediated disease? Immunol Today. 16: 27-33.
4. + T cells. Annu. Rev. Immunol. 12:635-673.
5. Abbas, A., A.H. Lichtman, and J.S. Pober. 1991. Cellular and Molecular Immunology. W.B. Saunders Co., Philadelphia, PA. 240-277.
6. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science (Wash. DC). 259:1742-1745.
7. Stemme, S., J. Holm, and G.K. Hansson. 1992. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler. Thromb. 12:206-211.
8. Li, H., M.I. Cybulsky, M.A. Gimbrone, and P. Libby. 1993. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb. 13:197-204.
9. Jonasson, G.K., J. Holm, O. Skalli, G. Gabbiani, and G.K. Hansson. 1985. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J. Clin. Invest. 76:125-131.
10. Fyfe, A.I., J.-H. Qiao, and A.J. Lusis. 1994. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J. Clin. Invest. 94:2516-2520.
11. Li, H., M. W. Freeman, and P. Libby. 1995. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J. Clin. Invest. 95:122-133.
12. Fong, L.G., A.T. Fong, and A.D. Cooper. 1990. Inhibitions of mouse macrophage degradation of actyl-low density lipoproteins by interferons-γ. J. Biol. Chem. 265:11751-11760.
13. LaMarre, J., B.B. Wolf, E.L. Kittler, P.J. Quesenberry, and S.L. Gonias. 1993. Regulation of macrophage α2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-γ. J. Clin. Invest. 91:1219-1224.
14. Libby, P. 1995. Molecular basis of the acute coronary syndromes. Circulation. 91:2844-2850.
15. Warner, S.J., G.B. Friedman, and P. Libby. 1989. Immune interferon inhibits proliferation and induces 2′-5′-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. J. Clin. Invest. 83:1174-1182.
16. Hansson, G.K., M. Hellstraand, L. Rymo, L. Rubbia, and G. Gabbiani. 1989. Interferon-γ inhibits smooth muscle cell proliferation and expression of differentiation-specific α-smooth muscle actin in arterial smooth muscle cells. J. Exp. Med. 170:1595-1608.
17. Farrar, M.A., and R.D. Schreiber. 1993. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11:571-611.
18. Shuai, K., C. Schindler, V. Prezioso, and J.E. Darnell. 1992. Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91-kDa DNA binding protein. Science (Wash. DC). 258:1808-1812.
19. Schindler, C., and J.E. Darnell. 1995. Transcriptional responses to peptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621-651.
20. Pernis, A., S. Gupta, K. Gollob, E. Garfein, B. Coffman, C. Schindler, and P. Rothman. 1995. Lack of interferon-γ receptor β-chain and the prevention of interferon-γ signaling in Th1 cells. Science (Wash. DC). 269:245-247.
21. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science (Wash. DC). 259:1739-1742.
22. Plump, A.S., J.D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
23. Nakashima, Y., A.S. Plump, E.W. Raines, J.L. Breslow, and R. Ross. 1994. ApoE-deficient mice develop lesions in all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:133-140.
24. Zhang, S.H., R.L. Reddick, J.A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science (Wash. DC). 258:468-471.
25. Azam, M., H. Erdjument-Bromage, B.L. Kreider, M. Xia, F. Quelle, R. Basu, C. Saris, P. Tempst, J.N. Ihle, and C. Schindler. 1995. Interleukin-3 signals through multiple isoforms of Stat5. EMBO (Eur. Mol. Biol. Organ.) J. 14: 1402-1411.
26. Paigen, B., A. Morrow, P.A. Holmes, D. Mitchell, and R.A. Williams. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:231-240.
27. Rubin, E.M., R.M. Krauss, E.A. Spangler, J.G. Verstuyft, and S.M. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature (Lond.). 353:265-267.
28. Homanics, G.E., H.V. deSilva, J. Osada, S.H. Zhang, H. Wong, J. Borensztajn, and N. Maeda. 1995. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J. Biol. Chem. 270:2974-2980.
29. Roselaar, S.E., P.X. Kakkanathu, and A. Daugherty. 1996. Lymphocyte populations in atherosclerotic lesions of apoE -/-and LDL receptor -/- mice. Arterioscler. Thromb. Vasc. Biol. 16:1013-1018.
30. Zhou, X., S. Stemme, and G. Hansson. 1996. Evidence for a local immune response in atherosclerosis. Am. J. Pathol. 149:359-366.
31. Tall, A.R., and P.H. Green. 1981. Incorporation of phosphatidylcholine into spherical discoidal lipoproteins during incubation of egg phosphatidylcholine vesicles with isolated high density lipoproteins or with plasma. J. Biol. Chem. 256:2035-2044.
32. Reue, K., D.A. Purcell-Huynh, T.H. Leete, M.H. Doolittle, A. Durstenfeld, and A.J. Lusis. 1993. Genetic variation in mouse apolipoprotein A-I expression is determined pre-and post-transcriptionally. J. Lipid Res. 34:893-903.
33. Duverger, N., G. Tremp, J.-M. Cailaud, F. Emmanuel, A. Taileux, L. Nihoul, C. Fievet, G. Castro, J.C. Fruchart, and P. Denefle. 1995. Overexpression of human apolipoprotein AIV in transgenic mice inhibits atherosclerosis development. Circulation. 92:I-359.
34. Duverger, N., G. Tremp, J.M. Caillaud, F. Emmanuel, G. Castro, J.C. Fruchart, A. Steinmetz, and P. Denefle. 1996. Protection against atherogenesis in mice by human apolipoprotein A-IV. Science (Wash. DC). 273:966-968.
35. Jonasson, L., J. Holm, O. Skalli, G. Bondjers, and G.K. Hansson. 1986. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 6:131-138.
36. van der Wal, A.C., A.E. Becker, C.M.v.d. Loos, and P.K. Das. 1994. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:36-44.
37. Geng, Y., and G.K. Hansson. 1992. Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest. 89:1322-1330.
38. Jonasson, L., G.K. Hansson, G. Bondjers, L. Noe, and J. Etienne. 1990. Interferon-γ inhibits lipoprotein lipase in human monocyte-derived macrophages. Biochim. Biophys. Acta. 1053:43-48.
39. Ross, R. 1994. The role of lymphocytes in inflammation. Proc. Natl. Acad. Sci. USA. 91:2879.
40. Peoples, G.E., S. Blotnick, K. Takahashi, M.R. Freeman, M. Klagsbrun, and T.J. Eberlein. 1995. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc. Natl. Acad. Sci. USA. 92:6547-6551.
41. Stemme, S., B. Faber, J. Holm, O. Wilkund, J.L. Witzum, and G.K. Hansson. 1995. T lymphocytes from human atherosclerotic plaques recognized oxidized density lipoprotein. Proc. Natl. Acad. Sci. USA. 92:3893-3897.
42. Lorshbach, R.B., W.J. Murphy, C.J. Lowenstein, S.H. Snyder, and S.W. Russell. 1993. Expression of nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. J. Biol. Chem. 268:1908-1913.
43. Marui, N., M. Offermann, R. Swerlick, C. Raosen, M. Ahmad, R. Alexander, and R. Medford. 1993. VCAM-1 gene transcription and expression are regulated through an oxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92:1866-1874.
44. Xie, Q., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NFkB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705-4708.
45. Bauerle, P.A. 1991. The inducible transcription activator NFkB: regulation by distinct subunits. Biochim. Biophys. Acta. 1072:63-80.
46. Smith, J.D., E. Trogan, M. Ginsberg, C. Grigaux, J. Tian, and M. Miyata. 1995. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci., USA. 92:8264-8268.
47. Shi, C., W.-S. Lee, Q. He, D. Zhang, D. Fletcher, J.B. Newell, and E. Haber. 1996. Immunologic basis of transplant-associated arteriosclerosis. Proc. Natl. Acad. Sci. USA. 93:4051-4056.
48. Russell, P.S., C.M. Chase, H.J. Winn, and R.B. Colvin. 1994. Coronary atherosclerosis in transplanted mouse hearts. Transplantation (Baltimore). 9: 1367-1371.
49. Koyama, H., E.W. Raines, K.E. Bornfeldt, J.M. Roberts, and R. Ross. 1996. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of cdk2 inhibitors. Cell. 87:1069-1078.
50. Adams, C.W., Y.H. Abdulla, O.B. Bayliss, and R.S. Morgan. 1967. Modification of aortic atheroma and fatty liver in cholesterol-fed rabbits by intervenous injection of saturated and polyunsaturated lecithins. J. Pathol. Bacteriol. 94:77-87.
51. Friedman, M., S.O. Byers, and R.H. Rosenman. 1957. Resolution of aortic atherosclerotic infiltration in rabbit by phosphatide infusion. Proc. Soc. Exp. Biol. Med. 95:586-588.
52. Cressman, D.W., L.E. Greenbaum, R.A. DeAngelis, G. Ciliberto, E.E. Furth, V. Poli, and R. Taub. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science (Wash. DC). 274:1379-1383.
53. Bisaha, J.G., T.C. Simon, J.I. Gordon, and J.L. Breslow. 1995. Characterization of an enhancer element in the human apolipoprotein C-III gene that regulates human apolipoprotein gene expression in the intestinal epithelium. J. Biol. Chem. 270:19979-19988.